BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2015 10:38:00 AM | Browse: 1696 | Download: 2316
Publication Name World Journal of Gastroenterology
Manuscript ID 14910
Country Spain
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C
Manuscript Source Unsolicited Manuscript
All Author List Sabela Lens, Jose L Calleja, Ana Campillo, Jose A Carrión, Teresa Broquetas, Christie Perello, Juan de la Revilla, Zoe Mariño, María-Carlota Londoño, Jose M Sánchez-Tapias, Álvaro Urbano-Ispizua and Xavier Forns
Funding Agency and Grant Number
Funding Agency Grant Number
Instituto de Salud Carlos III PI11/01907(in part)
Ministerio de Economía y Competitividad, co-funded by Fondo Europeo de Desarrollo Regional, Unión Europea, Una manera de hacer Europa
Roche Organ Transplantation Research Foundation 442035057(to Forns X)
Corresponding Author Sabela Lens, MD, Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, C/Villarroel 170, 08036 Barcelona, Spain. slens@clinic.ub.es
Key Words Aplastic anemia; Hepatitis C; Telaprevir; Interferon; Protease inhibitors
Core Tip Addition of the new directly acting antivirals, Telaprevir and Boceprevir, clearly improved sustained virological response rates in patients with chronic hepatitis C. However, these combinations have also increased the risk of serious adverse events, especially in patients with advanced liver fibrosis. We describe the development of severe pancytopenia and aplastic anemia during triple therapy with telaprevir in patients with advanced liver disease (before or after liver transplantation). Close monitoring is imperative in this setting to promptly detect serious hematological disorders and to prevent further complications.
Publish Date 2015-05-13 10:38
Citation Lens S, Calleja JL, Campillo A, Carrión JA, Broquetas T, Perello C, de la Revilla J, Mariño Z, Londoño MC, Sánchez-Tapias JM, Urbano-Ispizua Á, Forns X. Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C. World J Gastroenterol 2015; 21(17): 5421-5426
URL http://www.wjgnet.com/1007-9327/full/v21/i17/5421.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i17.5421
Full Article (PDF) WJG-21-5421.pdf
Full Article (Word) WJG-21-5421.doc